⌕
ADMA Biologics · ADMA · Nasdaq
Tenet 72 · Solid
Compare
$13.47−1.54%At closeTenet 72 · Solid
$13.47−0.21 (−1.54%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

ADMA Biologics (ADMA) Institutional Ownership

13F filers reported holding 93.4% of ADMA Biologics (ADMA) shares as of Jun 30, 2026, across 324 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

4 figures withheld by our checks. Each blank figure names its reason.

Held by 13F filers
93.4%
Jun 30, 2026
13F filers
324
quarter ended Jun 30, 2026
13F value
$1.7B
207.3M shares

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 324 13F filers for Jun 30, 2026, over shares outstanding implied from the current quote, measured 140 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 5, 2026Grossman Adam SPresident and CEOAcquired · Option exercise105,000$5.40↗
Nov 5, 2026Grossman Adam SPresident and CEODisposed · Open-market sale105,000$12.00↗
Nov 5, 2026Grossman Adam SPresident and CEODisposed · Open-market sale42,000$12.00↗
Nov 5, 2026Grossman Adam SPresident and CEODisposed · Option exercise105,000Stock Option (Right to Buy)—↗
Jul 24, 2026Kestenberg-Messina Kaitlin M.COO and SVP, ComplianceDisposed · Tax withholding3,177$8.37↗
Jul 16, 2026Kohler TerryCFO and TreasurerAcquired · Grant / award85,130—↗
Jul 16, 2026Kohler TerryCFO and TreasurerAcquired · Grant / award136,363Stock Option (Right to Buy)—↗
May 27, 2026Grossman Jerrold BdirectorAcquired · Open-market buy6,400$7.91↗
May 12, 2026Grossman Jerrold BdirectorAcquired · Open-market buy12,500$8.01↗
May 11, 2026Grossman Jerrold BdirectorAcquired · Open-market buy12,500$8.01↗
Apr 1, 2026Kestenberg-Messina Kaitlin M.COO and SVP, ComplianceDisposed · Tax withholding20,362$9.11↗
Mar 17, 2026Guiheen Lawrence P.directorDisposed · Gift30,000—↗
Mar 17, 2026Guiheen Lawrence P.directorAcquired · Gift30,000—↗
Mar 16, 2026Grossman Adam SPresident and CEOAcquired · Option exercise15,000$5.40↗
Mar 16, 2026Grossman Adam SPresident and CEODisposed · Open-market sale15,000$15.16↗
Mar 16, 2026Grossman Adam SPresident and CEODisposed · Open-market sale6,000$15.16↗
Mar 16, 2026Grossman Adam SPresident and CEODisposed · Option exercise15,000Stock Option (right to buy)—↗
Mar 13, 2026Guiheen Lawrence P.directorAcquired · Option exercise30,000$3.66↗
Mar 13, 2026Guiheen Lawrence P.directorDisposed · Option exercise30,000Stock Option (Right to Buy)—↗
Mar 9, 2026Kestenberg-Messina Kaitlin M.COO and SVP, ComplianceDisposed · Other91,266—↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of ADMA Biologics do institutions hold?

13F filers reported holding 93.4% of ADMA Biologics' shares as of Jun 30, 2026, across 324 filers.

How many 13F filers hold ADMA Biologics?

ADMA Biologics was held by 324 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.